glp 1 mechanism of action diabetes Frontiers GLP-1: Actions on Beta-cell Mass

TEST-DM1 Study Group

Your doctor may prescribe GLP-1s for weight loss if you have an initial BMI of 30 or higher, or for those with a BMI of 27 or higher and one of these weight-related health conditions: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea PCOS Typically, these medications are prescribed only after someone has tried other weight loss methods, such as diet and exercise, without success

Am J Psychiatry 180(8):565572 Leggio L, Hendershot CS, Farokhnia M, Fink-Jensen A, Klausen MK, Schacht JP, Simmons WK (2023) GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

Rybelsus (semaglutide): An oral formulation of semaglutide manufactured by Novo Nordisk, Rybelsus has been named in MDL 3094

doi: 10.1345/aph.1Q024 88 AstrupACarraroRFinerNHarperAKunesovaMLeanMEJet al

doi: 10.1111/bph.15535